Results 181 to 190 of about 775,328 (297)

Tumor-naïve multimodal profiling of circulating tumor DNA to detect minimal residual disease in solid tumors. [PDF]

Ther Adv Med Oncol
Nguyen T, Nguyen Hoang VA, Nguyen TH, Tran TH, Nguyen N, Le Vo TT, Nguyen DS, Giang H, Nguyen HN, Tu LN.   +9 more
europepmc   +1 more source

Circulating tumor DNA-guided early detection and minimal residual disease monitoring in pancreatic and biliary cancers: evidence, barriers, and opportunities. [PDF]

World J Surg Oncol
Liu R, Yang Y, Hu Z, Fu Y.
europepmc   +1 more source

Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making. [PDF]

Cancers (Basel)
Theocharopoulos C, Machairas N, Ziogas IA, Mungo B, Del Chiaro M, Glatzounis GK, Schulick R, Sotiropoulos GC.   +7 more
europepmc   +1 more source

Adaptive therapy for perioperative non-small cell lung cancer: strategies guided by dynamic minimal residual disease adjustment. [PDF]

Transl Oncol
Xie LJ, Fu LL, Liu SC, Bai CS, Xu BC, He XW, Lin HF, Zeng YC, Tang WJ.   +8 more
europepmc   +1 more source

Minimal residual disease assessment following CD19‐targeted therapy in B‐cell precursor acute lymphoblastic leukemia using standardized 12‐color flow cytometry: A EuroFlow study [PDF]

Martijn W. C. Verbeek, Michaela Reiterová, Anna Laqua, Beatriz Rodríguez‐Roca, Łukasz Sędek, Chiara Buracchi, Malicorne Buysse, Elen Oliveira, Robby Engelmann, Joana Desterro, Anja X. De Jong, Sebastian Böettcher, Romana Jugooa, Susana Bárrena, Saskia Kohlscheen, Stefan Nierkens, Joana G. Rodriques, Mattias Hofmans, Giuseppe Gaipa, Elaine Sobral de Costa, Ester Mejstříková, Tomasz Szczepański, Monika Brüggemann, Jacques J. M. van Dongen, Alberto Órfão, Vincent H. J. van der Velden   +25 more
openalex   +1 more source

CD304 is preferentially expressed on a subset of B‐lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry [PDF]

, 2011
Françoise Solly, Fanny Angelot, Richard Garand, Christophe Ferrand, Estelle Seillès, Françoise Schillinger, Agnès Decobecq, Maryse Billot, Fabrice Larosa, Emmanuel Plouvier, Éric Deconinck, Faézeh Legrand, Philippe Saas, Pierre‐Simon Rohrlich, Francine Garnache‐Ottou   +14 more
openalex   +1 more source

Tumor <i>In Situ</i> Fluid Was Used to Characterize Glioma in Real-Time to Monitor Minimal Residual Disease and Tumor DNA Relapse

, 2021
Jinliang Yu, Zhiyuan Sheng, Yushuai Gao, Zhaoyue Yan, Chaojie Bu, Jianjun Gu, Yage Bu, Kaiyuan Deng, Shuang Wu, Sensen Xu, Sen Hu, Nianxuan Li, Zhongcan Chen, Ajmal Zemmar, Fitri Sepviyanti Sumardi, Juha Hernesniemi, Lingfei Kong, Gang Liu, Meiyun Wang, Tianxiao Li, Xingyao Bu   +20 more
openalex   +1 more source

Accuracy of ctDNA-based minimal residual disease detection in predicting postoperative recurrence of breast cancer: a meta-analysis. [PDF]

Front Oncol
You H, He J, Tian T.
europepmc   +1 more source

Correction: Liquid biopsy for minimal residual disease and monitoring in early-stage non-small cell lung cancer: current clinical utility and implementation challenges

Yoshiharu Sato
openalex   +1 more source

Bone marrow aspirate Cit-H3 was identified as a novel biomarker of minimal residual disease in neuroblastoma. [PDF]

BMC Cancer
Zhang M, Wang X, Liu L, Ni Y, Zhang Y, Hu X, Huang C, Gong B, She T, Chen C.   +9 more
europepmc   +1 more source